Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
11/2003
11/25/2003US6653290 Tumor proliferation inhibitors
11/25/2003US6653109 Method of producing derivatives of lactosamine
11/20/2003WO2003095608A2 Dna microarrays comprising active chromatin elements and comprehensive profiling therewith
11/20/2003WO2003095468A1 4'-deoxy-4'-(s)-amido avermectin derivatives
11/20/2003WO2003095467A1 Synthesis of locked nucleic acid derivatives
11/20/2003WO2003095436A1 Benzoisoselenazole derivatives with anti-inflammation, antivirus and anti-thrombosis activity and their use
11/20/2003WO2003062783A3 Light addressable electrochemical detection of duplex structures
11/20/2003WO2002085310A3 Antibiotics aa-896
11/20/2003WO2002072779A3 Nucleic acid labeling compounds
11/20/2003US20030216575 Novel pyranosyl cytosines: pharmaceutical formulations and methods
11/20/2003US20030216349 Method for treating arrhythmias
11/20/2003CA2484667A1 4"-deoxy-4"-(s)-amido avermectin derivatives
11/20/2003CA2460679A1 Dna microarrays comprising active chromatin elements and comprehensive profiling therewith
11/19/2003EP1362593A1 Pharmaceutical composition for diabetic neuropathy
11/19/2003EP1211259B1 Antibiotic caprazamycins and process for producing the same
11/19/2003EP0901500B1 In situ preparation of nucleoside phosphoramidites and their use in synthesis of oligonucleotides
11/18/2003US6649769 For labelling a polynucleotides
11/18/2003US6649753 Stable salts of S-adenosyl-L-methionine (SAMe) and the process for their preparation
11/18/2003US6649351 Methods for detecting a plurality of analytes by mass spectrometry
11/18/2003CA2264155C N6 heterocyclic substituted adenosine derivatives
11/18/2003CA2127472C New adenosine derivatives, preparation methods and pharmaceutical compositions containing them
11/13/2003WO2003093290A2 Nucleoside derivatives for treating hepatitis c virus infection
11/13/2003WO2003070174A3 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
11/13/2003US20030212082 Controlling neovascularization; angiogenesis inhibitors; therapy for strokes, cardiovascular disorders; antitumor agents; antidiabetic agents; antiarthritic agents; psoriasis
11/13/2003US20030212036 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory heptitis
11/13/2003US20030212032 Oligonucleotide N3'→P5' thiophosphoramidates: their synthesis and use
11/13/2003US20030212015 Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes
11/13/2003US20030211079 Immobilization with polyoxyethylene glycol; adjust circulation half-life
11/13/2003CA2484921A1 Nucleoside derivatives for treating hepatitis c virus infection
11/12/2003EP1361227A2 [5-carboxamide or 5-fluoro]-[2', 3'-unsaturated or 3'-modifield]-pyrimidine nucleosides
11/12/2003EP1360325A2 Multiplex quantification of nucleic acids in diseased cells
11/12/2003EP1280813B1 Anti-viral pyrimidine nucleoside analogues
11/12/2003EP1233973B1 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives
11/12/2003EP1140937B1 Antiviral nucleoside analogues
11/12/2003EP0970100B1 Benzimidazole derivatives
11/12/2003EP0840742A4 Systematic evolution of ligands by exponential enrichment: chemi-selex
11/12/2003CN1455683A Drugs for diagnosis of tissue-reproductive activity or treatment of proliferative disease
11/12/2003CN1127477C Methods and compositions for lipidization of hydrophilic molecules
11/11/2003US6646243 Fixing biopolymers to substrate; obtain substrate, incubate with nucleotide sequences, expose to activator, recover product
11/11/2003CA2264569C Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
11/06/2003WO2003091311A1 Monomers containing polyoxyalkylenes and polymer supports therefrom
11/06/2003WO2003091267A1 Process for preparing oligonucleotides
11/06/2003WO2003048179A3 Thermolabile hydroxyl protecting groups and methods of use
11/06/2003WO2003040395A3 Universal nucleotides for nucleic acid analysis
11/06/2003WO2003026589A3 Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
11/06/2003WO2002062811A3 Improved methods for synthesis of oligonucleotides
11/06/2003US20030208050 Nucleoside derivatives
11/06/2003US20030207841 Novel nucleoside and oligonucleotide analogues
11/06/2003US20030207825 Novel dinucleoside polyphosphates of general Formulae I, II and III, and formulations thereof which are selective ligands of the P2Y purinergic receptors. Applicants have discovered that dinucleoside polyphosphates of general Formulae I, II
11/06/2003US20030207824 Pyrimidine derivatives for labeled binding partners
11/06/2003US20030207328 Analyte assay using particulate labels
11/06/2003US20030207305 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds
11/06/2003US20030206887 RNA interference mediated inhibition of hepatitis B virus (HBV) using short interfering nucleic acid (siNA)
11/06/2003CA2483483A1 Process for preparing oligonucleotides
11/05/2003EP1358198A1 Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same
11/05/2003EP1358197A1 Hybrid protecting groups
11/05/2003EP1358152A1 Photolabile protective groups for the synthesis of biopolymers
11/05/2003EP1090020B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
11/05/2003CN1453287A One-kettle process of preparing 2,3'-anhydro-5'-O-(tert-pentenyl) thymidine and its derivative (oxo bridge compound)
11/05/2003CN1126546C Reduction of infarction region using citicoline
11/04/2003US6642367 Process for the synthesis of 2′-O-substituted pyrimidines and oligomeric compounds therefrom
11/04/2003US6642245 Treatment of HIV and HBV infections in humans
11/04/2003US6642210 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists
11/04/2003US6642206 Monocyclic L-nucleosides, analogs and uses thereof
11/04/2003CA2296109C Improved process for antiparasitic agent
11/04/2003CA2101281C Method of purifying nucleoside derivatives
10/2003
10/30/2003WO2003089670A2 Reagents for monitoring nuclei acid amplification and methods of using same
10/30/2003WO2003089448A1 Ibuprofen ribavirin ester, its method of preparation and use
10/30/2003WO2003088978A1 Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker, calcium channel blocker or a cardiac glycoside
10/30/2003WO2003029264A3 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
10/30/2003WO2003012051A3 Inhibitor of dna methylation
10/30/2003US20030204080 Such as 9-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl) adenine; for treatment of HIV
10/30/2003US20030204079 Process for producing 2', 3'-diethy substituted nucleoside derivatives
10/30/2003US20030204078 Contacting N4-acetyl-5',3'-di-O-acetyl-2'-O- methyl cytidine with Lewis acid to form 2'-)-methyladenosine nucleoside which is converted to phosphoramidite
10/30/2003US20030203872 Such as 1-(4-thio-beta-D-arabinofuranosyl)cytosine for treatment of cancer; gene expression inhibition
10/30/2003US20030203860 Substituted sugar derivatives of indolopyrrolocarbazoles, useful in inhibiting the proliferatin of tumor cells
10/30/2003US20030203852 Acyl pseudodipeptides which carry a functionalised auxialiary arm
10/30/2003CA2482928A1 Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker, calcium channel blocker or a cardiac glycoside
10/30/2003CA2482767A1 Reagents for monitoring nuclei acid amplification and methods of using same
10/29/2003EP1355916A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
10/29/2003EP1355915A1 Labelling compounds for the simple synthesis of 3'(18f)fluoro-3'-deoxy thymidine and a method for the production thereof
10/29/2003EP1355652A2 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders
10/29/2003CN1452627A 3'-prodrugs of 2'-deoxy-beta-L-nucleosides
10/28/2003US6639088 Hydrocarbyldithiomethyl-modified compound; for use in chemically synthesizing oligonucleotides and for sequencing
10/28/2003US6639062 Oligonucleotides which elicit ribonuclease for cleavage in complementary nucleic acid strand, having increased binding affinity/nuclease resistance; for medical diagnosis, gene therapy
10/28/2003US6639061 C3′-methylene hydrogen phosphonate oligomers and related compounds
10/28/2003US6639059 Synthesis of [2.2.1]bicyclo nucleosides
10/28/2003US6638914 Pharmaceutical administration of adenosine agonists
10/28/2003CA2213099C S-(+)-adenosylmethionine and 3'-azido-2',3'-dideoxy-nucleoside complexes as potent inhibitors of hiv-replication
10/23/2003WO2003087765A2 System for tracing animal products
10/23/2003WO2003087130A2 Process for manufacturing purified phosphorodiamidite
10/23/2003WO2003087119A1 METHOD FOR SYNTHESIZING β-L-FLUORO-2´,3´DIDEHYDROCYTIDINE (β-L-FD4C)
10/23/2003WO2003087118A2 Method for producing beta-l-2'deoxy-thymidine
10/23/2003WO2003087053A2 Reagent and process for protecting nucleoside active groups
10/23/2003WO2003086408A1 Use of a2a adenosine receptor agonists for the treatment of inflammatory diseases
10/23/2003WO2003050242A3 Dna amplification and sequencing using dna molecules generated by random fragmentation
10/23/2003US20030199686 Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines
10/23/2003US20030199474 Administering compounds such as (3,4-dihydroxy-5-(2-hydroxyethyl)-tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione for inhibiting the invasion and/or metastasis of a carcinoma in a mammal
10/23/2003US20030199461 3-beta-D-ribofuranosylthiazolo[4-5-d]pyridimine nucleosides and uses thereof
10/23/2003US20030198989 For use as a diagnostic reagent for detecting the presence or absence of a target molecule in a sample; Systematic Evolution of Ligands by EXponential enrichment (SELEX)
1 ... 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 ... 201